867 related articles for article (PubMed ID: 17398176)
1. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL
Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176
[TBL] [Abstract][Full Text] [Related]
2. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
Gotsman I; Stabholz A; Planer D; Pugatsch T; Lapidus L; Novikov Y; Masrawa S; Soskolne A; Lotan C
Isr Med Assoc J; 2008 Jul; 10(7):494-8. PubMed ID: 18751625
[TBL] [Abstract][Full Text] [Related]
3. Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial Results.
Ferencik M; Mayrhofer T; Lu MT; Bittner DO; Emami H; Puchner SB; Meyersohn NM; Ivanov AV; Adami EC; Voora D; Ginsburg GS; Januzzi JL; Douglas PS; Hoffmann U
JACC Cardiovasc Imaging; 2022 Aug; 15(8):1427-1438. PubMed ID: 35926901
[TBL] [Abstract][Full Text] [Related]
4. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
[TBL] [Abstract][Full Text] [Related]
5. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines.
Kim JY; Choi EY; Mun HS; Min PK; Yoon YW; Lee BK; Hong BK; Rim SJ; Kwon HM
Cardiovasc Diabetol; 2013 Oct; 12():140. PubMed ID: 24088407
[TBL] [Abstract][Full Text] [Related]
7. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
Koc M; Karaarslan O; Abali G; Batur MK
Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
[TBL] [Abstract][Full Text] [Related]
8. Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level.
Dai X; Deng J; Yu M; Lu Z; Shen C; Zhang J
Int J Cardiovasc Imaging; 2020 Apr; 36(4):723-730. PubMed ID: 31907683
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease.
Sentürk T; Cordan J; Baran I; Ozdemir B; Güllülü S; Aydinlar A; Göral G
Acta Cardiol; 2007 Apr; 62(2):135-41. PubMed ID: 17536601
[TBL] [Abstract][Full Text] [Related]
10. High-sensitivity troponin T level and angiographic severity of coronary artery disease.
Ndrepepa G; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A
Am J Cardiol; 2011 Sep; 108(5):639-43. PubMed ID: 21676369
[TBL] [Abstract][Full Text] [Related]
11. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention.
Liu Y; Jia SD; Yao Y; Tang XF; Xu N; Jiang L; Gao Z; Chen J; Yang YJ; Gao RL; Xu B; Yuan JQ
J Cardiol; 2020 Jan; 75(1):60-65. PubMed ID: 31416781
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease.
Arroyo-Espliguero R; Avanzas P; Quiles J; Kaski JC
Atherosclerosis; 2009 May; 204(1):239-43. PubMed ID: 18823889
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein elevation and disease activity in patients with coronary artery disease.
Arroyo-Espliguero R; Avanzas P; Cosín-Sales J; Aldama G; Pizzi C; Kaski JC
Eur Heart J; 2004 Mar; 25(5):401-8. PubMed ID: 15033252
[TBL] [Abstract][Full Text] [Related]
15. Association between interleukin-6 and the risk of cardiac events measured by coronary computed tomography angiography.
Zhao L; Wang X; Yang Y
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1237-1244. PubMed ID: 28233119
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
[TBL] [Abstract][Full Text] [Related]
17. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation.
Kang WC; Il Moon C; Lee K; Han SH; Suh SY; Moon J; Shin MS; Ahn T; Shin EK
Coron Artery Dis; 2011 Dec; 22(8):526-32. PubMed ID: 21909023
[TBL] [Abstract][Full Text] [Related]
18. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
19. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
Atherosclerosis; 2015 May; 240(1):216-21. PubMed ID: 25801014
[TBL] [Abstract][Full Text] [Related]
20. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation.
Akboga MK; Canpolat U; Sahinarslan A; Alsancak Y; Nurkoc S; Aras D; Aydogdu S; Abaci A
Atherosclerosis; 2015 May; 240(1):110-4. PubMed ID: 25770689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
